IMA – imagenebio, inc. (US:NASDAQ)
Stock Stats
News
DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing [Yahoo! Finance]
ImageneBio (NASDAQ:IMA) is now covered by analysts at Wedbush. They set an "underperform" rating and a $2.00 price target on the stock.
ImageneBio (NASDAQ:IMA) was downgraded by analysts at Wall Street Zen
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team [Yahoo! Finance]
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
Form SCHEDULE 13G ImageneBio, Inc. Filed by: Funicular Funds, LP
Form 4 ImageneBio, Inc. For: Dec 30 Filed by: Butler Erin
Form 4 ImageneBio, Inc. For: Dec 24 Filed by: SLATTERY JOSEPH P
Form 4 ImageneBio, Inc. For: Dec 18 Filed by: Wang Jonathan Jian
Form 4 ImageneBio, Inc. For: Dec 18 Filed by: Wang Stephen Hui
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.